First, the Tang Prize in Biopharmaceutical Sciences, sponsored by Taiwan, is going to Habener, Mojsov, and Holst [63]
Although the majority of these reviews show positive data for the potential of GLP-1 drugs for addiction, the findings are somewhat inconclusive due to study variability and patient differences, demonstrating that more focused clinical studies with addiction as a primary endpoint are needed
Shorter needles (6mm or 8mm) work well for subcutaneous injection in most body types
Who Should Use It: Those struggling with dull or uneven skin tone Individuals frequently exposed to sunlight or pollution Users already supplementing with collagen or glutathione Usage Tip: Best taken in the morning to protect skin from oxidative stress throughout the day
Wegovy also comes with a boxed warning: Risk of thyroid cancer
Whilst mild bloating is relatively common during GLP-1 therapy and often resolves with time and dietary adjustments, certain symptoms warrant prompt medical evaluation